Does lasofoxifene reduce the risks of both overall and ER+ invasive breast cancer in postmenopausal women with osteoporosis? Journal of the National Cancer Institute
Follicular lymphomas are the most frequently occurring low-grade lymphomas, and relapse is common. These authors examine a multi-pronged approach to treat relapse. Clinical Lymphoma & Myeloma
In this Expert Interview from SABCS 2007, Dr. Clifford Hudis comments about adjuvant chemotherapy in breast cancer, with particular emphasis on when and for whom treatment should be offered. Medscape Hematology-Oncology
For patients with testicular cancer in complete remission, is a postchemotherapy retroperitoneal lymph node dissection needed? Dr. Howard Hochster reports on a study that answers this question. Medscape Hematology-Oncology
The announcement that a trial of iniparib in breast cancer did not meet a primary endpoint prompted Dr. Kathy Miller to call for immediate disclosure of the data, the lack of which affects treatment. Medscape Hematology-Oncology
